APO Research
Talk to an analyst

APO RESEARCH · REPORT

Androstenedione

Androstenedione: 4-Androstenedione (androst-4-ene-3,17-dione) – an endogenous weak androgen and estrogen and intermediate to/prohormone of testosterone.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Androstenedione: 4-Androstenedione (androst-4-ene-3,17-dione) – an endogenous weak androgen and estrogen and intermediate to/prohormone of testosterone.

Androstenedione is used to evaluate the function of the adrenal gland and the ovaries or the testicles as well as the production of hormones related to the development of male sex organs and physical characteristics (androgens). It is most commonly used to determine the cause of symptoms of excess androgens in a woman who has an elevated testosterone level, along with a few other laboratory tests for this purpose.

Androstadienedione (1,4-androstadiene-3,17-dione) is an important industrial precursor for various steroid hormones. Androstadienedione is an important industrial-scale precursor for a wide variety of steroid hormones within the estrane and androstane classifications.

In the report, the data bases on androstenedione and androstadienedione.

Selected research

Market Structure

Global Androstenedione Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

1 January 2026192 pages

Choose your research edition.

Industry ResearchAndrostenedione Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Androstenedione Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Androstenedione Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Androstenedione Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Androstenedione Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Androstenedione: 4-Androstenedione (androst-4-ene-3,17-dione) – an endogenous weak androgen and estrogen and intermediate to/prohormone of testosterone.

Androstenedione is used to evaluate the function of the adrenal gland and the ovaries or the testicles as well as the production of hormones related to the development of male sex organs and physical characteristics (androgens). It is most commonly used to determine the cause of symptoms of excess androgens in a woman who has an elevated testosterone level, along with a few other laboratory tests for this purpose.

Androstadienedione (1,4-androstadiene-3,17-dione) is an important industrial precursor for various steroid hormones. Androstadienedione is an important industrial-scale precursor for a wide variety of steroid hormones within the estrane and androstane classifications.

Read the full market overview

In the report, the data bases on androstenedione and androstadienedione.

Androstenedione production is concentrated relatively. Currently, there are several producing companies in the world androstenedione industry. The main market players are BIOVET, Indo Phyto Chemicals, Sito Bio, Goto Pharmaceutical, Tianjin King York and Jiufu. Tianjin King York is the leader in the global market, with about 16% market shares.

China is the largest production region and the share reached 77.68% in 2015. The shares of Europe, India and Asia Other were 11.51%, 2.58% and 2.79%.

This report provides an overview of the global Androstenedione market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Androstenedione and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Androstenedione sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Androstenedione market size, projected growth trends, production technologies, key applications, and end-use industries.

Androstenedione Segment by Company

BIOVET

Indo Phyto Chemicals

Sito Bio

Goto Pharmaceutical

Tianjin King York

Jiufu

Yongning Pharma

Jiangxi Hongyuan Pharmaceutical

Kaizon

Xi’an Gaoyuan Bio-Chem

Dongyao Pharmaceutical

Huazhong Pharmaceutical

Darui

Danjiangkou Danao

Dahua Pharmaceutical

Androstenedione Segment by Type

Androstenedione

Androstadienedione

Androstenedione Segment by Application

Arthritis Pharmaceuticals

Fertility Control Pharmaceuticals

Infectious Inflammation Pharmaceuticals

Others

Androstenedione Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Androstenedione market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Androstenedione and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Androstenedione.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Androstenedione market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Androstenedione manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Androstenedione in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Androstenedione in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Androstenedione Industry Trends Table 2. Androstenedione Industry Drivers Table 3. Androstenedione Industry Opportunities and Challenges Table 4. Androstenedione Industry Restraints Table 5. Global Androstenedione Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Androstenedione Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Androstenedione Sales by Manufacturers (MT) & (2021-2026) Table 8. Global Androstenedione Sales Market Share by Manufacturers Table 9. Global Androstenedione Average Sales Price (USD/MT) of Manufacturers (2021-2026) Table 10. Global Androstenedione Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Androstenedione Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Androstenedione Manufacturers, Product Type & Application Table 13. Global Androstenedione Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Androstenedione by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Androstenedione Table 17. Major Manufacturers of Androstadienedione Table 18. Global Androstenedione Sales by Type 2021 VS 2025 VS 2032 (MT) Table 19. Global Androstenedione Sales by Type (2021-2026) & (MT) Table 20. Global Androstenedione Sales by Type (2027-2032) & (MT) Table 21. Global Androstenedione Sales Market Share by Type (2021-2026) Table 22. Global Androstenedione Sales Market Share by Type (2027-2032) Table 23. Global Androstenedione Revenue by Type 2021 VS 2025 VS 2032 (MT) Table 24. Global Androstenedione Revenue by Type (2021-2026) & (MT) Table 25. Global Androstenedione Revenue by Type (2027-2032) & (MT) Table 26. Global Androstenedione Revenue Market Share by Type (2021-2026) Table 27. Global Androstenedione Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Arthritis Pharmaceuticals Table 29. Major Manufacturers of Fertility Control Pharmaceuticals Table 30. Major Manufacturers of Infectious Inflammation Pharmaceuticals Table 31. Major Manufacturers of Others Table 32. Global Androstenedione Sales by Application 2021 VS 2025 VS 2032 (MT) Table 33. Global Androstenedione Sales by Application (2021-2026) & (MT) Table 34. Global Androstenedione Sales by Application (2027-2032) & (MT) Table 35. Global Androstenedione Sales Market Share by Application (2021-2026) Table 36. Global Androstenedione Sales Market Share by Application (2027-2032) Table 37. Global Androstenedione Revenue by Application 2021 VS 2025 VS 2032 (MT) Table 38. Global Androstenedione Revenue by Application (2021-2026) & (MT) Table 39. Global Androstenedione Revenue by Application (2027-2032) & (MT) Table 40. Global Androstenedione Revenue Market Share by Application (2021-2026) Table 41. Global Androstenedione Revenue Market Share by Application (2027-2032) Table 42. Global Androstenedione Sales by Region: 2021 VS 2025 VS 2032 (MT) Table 43. Global Androstenedione Sales by Region (2021-2026) & (MT) Table 44. Global Androstenedione Sales Market Share by Region (2021-2026) Table 45. Global Androstenedione Sales Forecasted by Region (2027-2032) & (MT) Table 46. Global Androstenedione Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Androstenedione Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 48. North America Androstenedione Sales by Country (2021-2026) & (MT) Table 49. North America Androstenedione Sales by Country (2027-2032) & (MT) Table 50. Europe Androstenedione Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 51. Europe Androstenedione Sales by Country (2021-2026) & (MT) Table 52. Europe Androstenedione Sales by Country (2027-2032) & (MT) Table 53. Asia Pacific Androstenedione Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 54. Asia Pacific Androstenedione Sales by Country (2021-2026) & (MT) Table 55. Asia Pacific Androstenedione Sales by Country (2027-2032) & (MT) Table 56. South America, Middle East and Africa Androstenedione Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 57. South America, Middle East and Africa Androstenedione Sales by Country (2021-2026) & (MT) Table 58. South America, Middle East and Africa Androstenedione Sales by Country (2027-2032) & (MT) Table 59. Global Androstenedione Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Androstenedione Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Androstenedione Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Androstenedione Revenue Market Share by Region (2021-2026) Table 63. Global Androstenedione Revenue Market Share by Region (2027-2032) Table 64. BIOVET Company Information Table 65. BIOVET Business Overview Table 66. BIOVET Androstenedione Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. BIOVET Androstenedione Product Portfolio Table 68. BIOVET Recent Development Table 69. Indo Phyto Chemicals Company Information Table 70. Indo Phyto Chemicals Business Overview Table 71. Indo Phyto Chemicals Androstenedione Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Indo Phyto Chemicals Androstenedione Product Portfolio Table 73. Indo Phyto Chemicals Recent Development Table 74. Sito Bio Company Information Table 75. Sito Bio Business Overview Table 76. Sito Bio Androstenedione Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Sito Bio Androstenedione Product Portfolio Table 78. Sito Bio Recent Development Table 79. Goto Pharmaceutical Company Information Table 80. Goto Pharmaceutical Business Overview Table 81. Goto Pharmaceutical Androstenedione Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Goto Pharmaceutical Androstenedione Product Portfolio Table 83. Goto Pharmaceutical Recent Development Table 84. Tianjin King York Company Information Table 85. Tianjin King York Business Overview Table 86. Tianjin King York Androstenedione Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Tianjin King York Androstenedione Product Portfolio Table 88. Tianjin King York Recent Development Table 89. Jiufu Company Information Table 90. Jiufu Business Overview Table 91. Jiufu Androstenedione Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Jiufu Androstenedione Product Portfolio Table 93. Jiufu Recent Development Table 94. Yongning Pharma Company Information Table 95. Yongning Pharma Business Overview Table 96. Yongning Pharma Androstenedione Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Yongning Pharma Androstenedione Product Portfolio Table 98. Yongning Pharma Recent Development Table 99. Jiangxi Hongyuan Pharmaceutical Company Information Table 100. Jiangxi Hongyuan Pharmaceutical Business Overview Table 101. Jiangxi Hongyuan Pharmaceutical Androstenedione Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Jiangxi Hongyuan Pharmaceutical Androstenedione Product Portfolio Table 103. Jiangxi Hongyuan Pharmaceutical Recent Development Table 104. Kaizon Company Information Table 105. Kaizon Business Overview Table 106. Kaizon Androstenedione Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Kaizon Androstenedione Product Portfolio Table 108. Kaizon Recent Development Table 109. Xi’an Gaoyuan Bio-Chem Company Information Table 110. Xi’an Gaoyuan Bio-Chem Business Overview Table 111. Xi’an Gaoyuan Bio-Chem Androstenedione Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Xi’an Gaoyuan Bio-Chem Androstenedione Product Portfolio Table 113. Xi’an Gaoyuan Bio-Chem Recent Development Table 114. Dongyao Pharmaceutical Company Information Table 115. Dongyao Pharmaceutical Business Overview Table 116. Dongyao Pharmaceutical Androstenedione Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Dongyao Pharmaceutical Androstenedione Product Portfolio Table 118. Dongyao Pharmaceutical Recent Development Table 119. Huazhong Pharmaceutical Company Information Table 120. Huazhong Pharmaceutical Business Overview Table 121. Huazhong Pharmaceutical Androstenedione Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Huazhong Pharmaceutical Androstenedione Product Portfolio Table 123. Huazhong Pharmaceutical Recent Development Table 124. Darui Company Information Table 125. Darui Business Overview Table 126. Darui Androstenedione Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Darui Androstenedione Product Portfolio Table 128. Darui Recent Development Table 129. Danjiangkou Danao Company Information Table 130. Danjiangkou Danao Business Overview Table 131. Danjiangkou Danao Androstenedione Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Danjiangkou Danao Androstenedione Product Portfolio Table 133. Danjiangkou Danao Recent Development Table 134. Dahua Pharmaceutical Company Information Table 135. Dahua Pharmaceutical Business Overview Table 136. Dahua Pharmaceutical Androstenedione Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Dahua Pharmaceutical Androstenedione Product Portfolio Table 138. Dahua Pharmaceutical Recent Development Table 139. Key Raw Materials Table 140. Raw Materials Key Suppliers Table 141. Androstenedione Distributors List Table 142. Androstenedione Customers List Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Androstenedione Product Image Figure 2. Global Androstenedione Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Androstenedione Market Size (2021-2032) & (US$ Million) Figure 4. Global Androstenedione Sales (2021-2032) & (MT) Figure 5. Global Androstenedione Average Price (USD/MT) & (2021-2032) Figure 6. Global Top 5 and 10 Androstenedione Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Androstenedione Image Figure 9. Androstadienedione Image Figure 10. Global Androstenedione Sales by Type (2021 VS 2025 VS 2032) & (MT) Figure 11. Global Androstenedione Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Androstenedione Sales Market Share by Type (2021-2032) Figure 13. Global Androstenedione Revenue by Type (2021 VS 2025 VS 2032) & (MT) Figure 14. Global Androstenedione Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Androstenedione Revenue Market Share by Type (2021-2032) Figure 16. Arthritis Pharmaceuticals Image Figure 17. Fertility Control Pharmaceuticals Image Figure 18. Infectious Inflammation Pharmaceuticals Image Figure 19. Others Image Figure 20. Global Androstenedione Sales by Application (2021 VS 2025 VS 2032) & (MT) Figure 21. Global Androstenedione Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Androstenedione Sales Market Share by Application (2021-2032) Figure 23. Global Androstenedione Revenue by Application (2021 VS 2025 VS 2032) & (MT) Figure 24. Global Androstenedione Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Androstenedione Revenue Market Share by Application (2021-2032) Figure 26. North America Androstenedione Sales and Growth Rate (2021-2032) & (MT) Figure 27. North America Androstenedione Sales Market Share by Country (2021-2032) Figure 28. U.S. Androstenedione Sales and Growth Rate (2021-2032) & (MT) Figure 29. Canada Androstenedione Sales and Growth Rate (2021-2032) & (MT) Figure 30. Mexico Androstenedione Sales and Growth Rate (2021-2032) & (MT) Figure 31. Europe Androstenedione Sales and Growth Rate (2021-2032) & (MT) Figure 32. Europe Androstenedione Sales Market Share by Country (2021-2032) Figure 33. Germany Androstenedione Sales and Growth Rate (2021-2032) & (MT) Figure 34. France Androstenedione Sales and Growth Rate (2021-2032) & (MT) Figure 35. U.K. Androstenedione Sales and Growth Rate (2021-2032) & (MT) Figure 36. Italy Androstenedione Sales and Growth Rate (2021-2032) & (MT) Figure 37. Netherlands Androstenedione Sales and Growth Rate (2021-2032) & (MT) Figure 38. Asia Pacific Androstenedione Sales and Growth Rate (2021-2032) & (MT) Figure 39. Asia Pacific Androstenedione Sales Market Share by Country (2021-2032) Figure 40. China Androstenedione Sales and Growth Rate (2021-2032) & (MT) Figure 41. Japan Androstenedione Sales and Growth Rate (2021-2032) & (MT) Figure 42. South Korea Androstenedione Sales and Growth Rate (2021-2032) & (MT) Figure 43. Southeast Asia Androstenedione Sales and Growth Rate (2021-2032) & (MT) Figure 44. India Androstenedione Sales and Growth Rate (2021-2032) & (MT) Figure 45. Australia Androstenedione Sales and Growth Rate (2021-2032) & (MT) Figure 46. South America, Middle East and Africa Androstenedione Sales and Growth Rate (2021-2032) & (MT) Figure 47. South America, Middle East and Africa Androstenedione Sales Market Share by Country (2021-2032) Figure 48. Brazil Androstenedione Sales and Growth Rate (2021-2032) & (MT) Figure 49. South Africa Androstenedione Sales and Growth Rate (2021-2032) & (MT) Figure 50. Saudi Arabia Androstenedione Sales and Growth Rate (2021-2032) & (MT) Figure 51. Turkey Androstenedione Sales and Growth Rate (2021-2032) & (MT) Figure 52. Argentina Androstenedione Sales and Growth Rate (2021-2032) & (MT) Figure 53. UAE Androstenedione Sales and Growth Rate (2021-2032) & (MT) Figure 54. Egypt Androstenedione Sales and Growth Rate (2021-2032) & (MT) Figure 55. Chile Androstenedione Sales and Growth Rate (2021-2032) & (MT) Figure 56. Global Androstenedione Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Androstenedione Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Androstenedione Revenue (2021-2032) & (US$ Million) Figure 59. North America Androstenedione Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Androstenedione Revenue (2021-2032) & (US$ Million) Figure 61. Europe Androstenedione Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Androstenedione Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Androstenedione Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Androstenedione Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Androstenedione Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Androstenedione Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Androstenedione Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Androstenedione
  • Androstadienedione
Applications
  • Arthritis Pharmaceuticals
  • Fertility Control Pharmaceuticals
  • Infectious Inflammation Pharmaceuticals
  • Others
Companies covered
  • BIOVET
  • Indo Phyto Chemicals
  • Sito Bio
  • Goto Pharmaceutical
  • Tianjin King York
  • Jiufu
  • Yongning Pharma
  • Jiangxi Hongyuan Pharmaceutical
  • Kaizon
  • Xi’an Gaoyuan Bio-Chem
  • Dongyao Pharmaceutical
  • Huazhong Pharmaceutical
  • Darui
  • Danjiangkou Danao
  • Dahua Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Androstenedione Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Androstenedione Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Androstenedione Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Androstenedione Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Androstenedione Market Dynamics
  1. 2.1 Androstenedione Industry Trends
  2. 2.2 Androstenedione Industry Drivers
  3. 2.3 Androstenedione Industry Opportunities and Challenges
  4. 2.4 Androstenedione Industry Restraints
3 Androstenedione Market by Manufacturers
  1. 3.1 Global Androstenedione Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Androstenedione Sales by Manufacturers (2021-2026)
  3. 3.3 Global Androstenedione Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Androstenedione Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Androstenedione Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Androstenedione Manufacturers, Product Type & Application
  7. 3.7 Global Androstenedione Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Androstenedione Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Androstenedione Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Androstenedione Tier 1, Tier 2, and Tier 3
4 Androstenedione Market by Type
  1. 4.1 Androstenedione Type Introduction
  2. 4.1.1 Androstenedione
  3. 4.1.2 Androstadienedione
  4. 4.2 Global Androstenedione Sales by Type
  5. 4.2.1 Global Androstenedione Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Androstenedione Sales by Type (2021-2032)
  7. 4.2.3 Global Androstenedione Sales Market Share by Type (2021-2032)
  8. 4.3 Global Androstenedione Revenue by Type
  9. 4.3.1 Global Androstenedione Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Androstenedione Revenue by Type (2021-2032)
  11. 4.3.3 Global Androstenedione Revenue Market Share by Type (2021-2032)
5 Androstenedione Market by Application
  1. 5.1 Androstenedione Application Introduction
  2. 5.1.1 Arthritis Pharmaceuticals
  3. 5.1.2 Fertility Control Pharmaceuticals
  4. 5.1.3 Infectious Inflammation Pharmaceuticals
  5. 5.1.4 Others
  6. 5.2 Global Androstenedione Sales by Application
  7. 5.2.1 Global Androstenedione Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Androstenedione Sales by Application (2021-2032)
  9. 5.2.3 Global Androstenedione Sales Market Share by Application (2021-2032)
  10. 5.3 Global Androstenedione Revenue by Application
  11. 5.3.1 Global Androstenedione Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Androstenedione Revenue by Application (2021-2032)
  13. 5.3.3 Global Androstenedione Revenue Market Share by Application (2021-2032)
6 Global Androstenedione Sales by Region
  1. 6.1 Global Androstenedione Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Androstenedione Sales by Region (2021-2032)
  3. 6.2.1 Global Androstenedione Sales by Region (2021-2026)
  4. 6.2.2 Global Androstenedione Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Androstenedione Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Androstenedione Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Androstenedione Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Androstenedione Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Androstenedione Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Androstenedione Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Androstenedione Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Androstenedione Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Androstenedione Revenue by Region
  1. 7.1 Global Androstenedione Revenue by Region
  2. 7.1.1 Global Androstenedione Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Androstenedione Revenue by Region (2021-2026)
  4. 7.1.3 Global Androstenedione Revenue by Region (2027-2032)
  5. 7.1.4 Global Androstenedione Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Androstenedione Revenue (2021-2032)
  8. 7.2.2 North America Androstenedione Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Androstenedione Revenue (2021-2032)
  11. 7.3.2 Europe Androstenedione Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Androstenedione Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Androstenedione Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Androstenedione Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Androstenedione Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 BIOVET
  2. 8.1.1 BIOVET Company Information
  3. 8.1.2 BIOVET Business Overview
  4. 8.1.3 BIOVET Androstenedione Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 BIOVET Androstenedione Product Portfolio
  6. 8.1.5 BIOVET Recent Developments
  7. 8.2 Indo Phyto Chemicals
  8. 8.2.1 Indo Phyto Chemicals Company Information
  9. 8.2.2 Indo Phyto Chemicals Business Overview
  10. 8.2.3 Indo Phyto Chemicals Androstenedione Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Indo Phyto Chemicals Androstenedione Product Portfolio
  12. 8.2.5 Indo Phyto Chemicals Recent Developments
  13. 8.3 Sito Bio
  14. 8.3.1 Sito Bio Company Information
  15. 8.3.2 Sito Bio Business Overview
  16. 8.3.3 Sito Bio Androstenedione Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sito Bio Androstenedione Product Portfolio
  18. 8.3.5 Sito Bio Recent Developments
  19. 8.4 Goto Pharmaceutical
  20. 8.4.1 Goto Pharmaceutical Company Information
  21. 8.4.2 Goto Pharmaceutical Business Overview
  22. 8.4.3 Goto Pharmaceutical Androstenedione Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Goto Pharmaceutical Androstenedione Product Portfolio
  24. 8.4.5 Goto Pharmaceutical Recent Developments
  25. 8.5 Tianjin King York
  26. 8.5.1 Tianjin King York Company Information
  27. 8.5.2 Tianjin King York Business Overview
  28. 8.5.3 Tianjin King York Androstenedione Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Tianjin King York Androstenedione Product Portfolio
  30. 8.5.5 Tianjin King York Recent Developments
  31. 8.6 Jiufu
  32. 8.6.1 Jiufu Company Information
  33. 8.6.2 Jiufu Business Overview
  34. 8.6.3 Jiufu Androstenedione Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Jiufu Androstenedione Product Portfolio
  36. 8.6.5 Jiufu Recent Developments
  37. 8.7 Yongning Pharma
  38. 8.7.1 Yongning Pharma Company Information
  39. 8.7.2 Yongning Pharma Business Overview
  40. 8.7.3 Yongning Pharma Androstenedione Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Yongning Pharma Androstenedione Product Portfolio
  42. 8.7.5 Yongning Pharma Recent Developments
  43. 8.8 Jiangxi Hongyuan Pharmaceutical
  44. 8.8.1 Jiangxi Hongyuan Pharmaceutical Company Information
  45. 8.8.2 Jiangxi Hongyuan Pharmaceutical Business Overview
  46. 8.8.3 Jiangxi Hongyuan Pharmaceutical Androstenedione Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Jiangxi Hongyuan Pharmaceutical Androstenedione Product Portfolio
  48. 8.8.5 Jiangxi Hongyuan Pharmaceutical Recent Developments
  49. 8.9 Kaizon
  50. 8.9.1 Kaizon Company Information
  51. 8.9.2 Kaizon Business Overview
  52. 8.9.3 Kaizon Androstenedione Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Kaizon Androstenedione Product Portfolio
  54. 8.9.5 Kaizon Recent Developments
  55. 8.10 Xi’an Gaoyuan Bio-Chem
  56. 8.10.1 Xi’an Gaoyuan Bio-Chem Company Information
  57. 8.10.2 Xi’an Gaoyuan Bio-Chem Business Overview
  58. 8.10.3 Xi’an Gaoyuan Bio-Chem Androstenedione Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Xi’an Gaoyuan Bio-Chem Androstenedione Product Portfolio
  60. 8.10.5 Xi’an Gaoyuan Bio-Chem Recent Developments
  61. 8.11 Dongyao Pharmaceutical
  62. 8.11.1 Dongyao Pharmaceutical Company Information
  63. 8.11.2 Dongyao Pharmaceutical Business Overview
  64. 8.11.3 Dongyao Pharmaceutical Androstenedione Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Dongyao Pharmaceutical Androstenedione Product Portfolio
  66. 8.11.5 Dongyao Pharmaceutical Recent Developments
  67. 8.12 Huazhong Pharmaceutical
  68. 8.12.1 Huazhong Pharmaceutical Company Information
  69. 8.12.2 Huazhong Pharmaceutical Business Overview
  70. 8.12.3 Huazhong Pharmaceutical Androstenedione Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Huazhong Pharmaceutical Androstenedione Product Portfolio
  72. 8.12.5 Huazhong Pharmaceutical Recent Developments
  73. 8.13 Darui
  74. 8.13.1 Darui Company Information
  75. 8.13.2 Darui Business Overview
  76. 8.13.3 Darui Androstenedione Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Darui Androstenedione Product Portfolio
  78. 8.13.5 Darui Recent Developments
  79. 8.14 Danjiangkou Danao
  80. 8.14.1 Danjiangkou Danao Company Information
  81. 8.14.2 Danjiangkou Danao Business Overview
  82. 8.14.3 Danjiangkou Danao Androstenedione Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Danjiangkou Danao Androstenedione Product Portfolio
  84. 8.14.5 Danjiangkou Danao Recent Developments
  85. 8.15 Dahua Pharmaceutical
  86. 8.15.1 Dahua Pharmaceutical Company Information
  87. 8.15.2 Dahua Pharmaceutical Business Overview
  88. 8.15.3 Dahua Pharmaceutical Androstenedione Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Dahua Pharmaceutical Androstenedione Product Portfolio
  90. 8.15.5 Dahua Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Androstenedione Value Chain Analysis
  2. 9.1.1 Androstenedione Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Androstenedione Production Mode & Process
  6. 9.2 Androstenedione Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Androstenedione Distributors
  9. 9.2.3 Androstenedione Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst